These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 2523658

  • 1. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L, Fruscio M, Gradnik R, Chianca R, Leonetti G, Zanchetti A.
    Am J Med; 1989 Apr 17; 86(4A):65-6. PubMed ID: 2523658
    [Abstract] [Full Text] [Related]

  • 2. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
    Wittenberg C, Rosenfeld JB.
    Am J Hypertens; 1991 Feb 17; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
    [Abstract] [Full Text] [Related]

  • 3. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B, Andersson OK, Wysocki M, Hedner T, Aurell M.
    Am J Med; 1989 Apr 17; 86(4A):60-4. PubMed ID: 2523657
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK, Häussler M, Ress KM, Müller GA, Burger KJ, Risler T.
    Eur J Clin Pharmacol; 1990 Apr 17; 39(4):333-5. PubMed ID: 2150190
    [Abstract] [Full Text] [Related]

  • 5. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
    Krusell LR, Jespersen LT, Schmitz A, Thomsen K, Pedersen OL.
    Hypertension; 1987 Dec 17; 10(6):577-81. PubMed ID: 2447016
    [Abstract] [Full Text] [Related]

  • 6. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
    Maccariello ER, Genelhu de Abreu Fagundes V, Francischetti EA.
    Am J Hypertens; 1997 May 17; 10(5 Pt 1):541-5. PubMed ID: 9160765
    [Abstract] [Full Text] [Related]

  • 7. Long-term effects of isradipine on blood pressure and renal function.
    Pedersen OL, Krusell LR, Sihm I, Jespersen LT, Thomsen K.
    Am J Med; 1989 Apr 17; 86(4A):15-8. PubMed ID: 2523650
    [Abstract] [Full Text] [Related]

  • 8. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
    Simonsen K, Sundstedt CD.
    Am J Med; 1989 Apr 17; 86(4A):91-3. PubMed ID: 2523663
    [Abstract] [Full Text] [Related]

  • 9. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
    Wysocki M, Andersson OK, Persson B, Bagge U.
    Angiology; 1998 Jan 17; 49(1):41-8. PubMed ID: 9456163
    [Abstract] [Full Text] [Related]

  • 10. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA, Marcó E, Gilbert HB, Raffaele P, Brito M, Giménez M, Moledo LI.
    Drugs; 1985 Jan 17; 30 Suppl 1():49-58. PubMed ID: 2994987
    [Abstract] [Full Text] [Related]

  • 11. Multicenter evaluation of the safety and efficacy of isradipine in hypertension. The Italian-Belgian Isradipine Study Group.
    Am J Med; 1989 Apr 17; 86(4A):94-7. PubMed ID: 2523664
    [Abstract] [Full Text] [Related]

  • 12. Additive effect of isradipine in combination with captopril in hypertensive patients.
    Eggertsen R, Svensson A, Dahlöf B, Hansson L.
    Am J Med; 1989 Apr 17; 86(4A):124-6. PubMed ID: 2523647
    [Abstract] [Full Text] [Related]

  • 13. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
    Frithz G, Aström B, Dahlöf B, Hansson L, Tollin C, Himanen P, Sundstedt CD.
    Am J Med; 1989 Apr 17; 86(4A):115-8. PubMed ID: 2523645
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
    Am J Med; 1989 Apr 17; 86(4A):110-4. PubMed ID: 2523644
    [Abstract] [Full Text] [Related]

  • 15. Long-term renal effects of isradipine, a calcium entry blocker, in essential hypertension.
    Persson B, Wysocki M, Andersson OK.
    J Cardiovasc Pharmacol; 1989 Jul 17; 14(1):22-4. PubMed ID: 2475710
    [Abstract] [Full Text] [Related]

  • 16. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
    McMahon FG, Vargas R, Ryan JR, Miller H, Faraday S.
    J Clin Pharmacol; 1988 Jul 17; 28(7):664-6. PubMed ID: 2975291
    [Abstract] [Full Text] [Related]

  • 17. Natriuretic effect of nitrendipine is preceded by transient systemic and renal hemodynamic effects.
    Krekels MM, Gaillard CA, Viergever PP, Van Es PN, Lavrijssen AT, De Leeuw PW.
    Cardiovasc Drugs Ther; 1997 Mar 17; 11(1):33-8. PubMed ID: 9140675
    [Abstract] [Full Text] [Related]

  • 18. Placebo-controlled trial of once-a-day isradipine monotherapy in mild to moderately severe hypertension.
    Winer N, Kirkendall WM, Canosa FL, Lewin AJ, McMahon FG, Carr AA, Cohen M.
    J Clin Pharmacol; 1990 Nov 17; 30(11):1006-11. PubMed ID: 2147029
    [Abstract] [Full Text] [Related]

  • 19. A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension. Isradipine in Hypertension Study Group.
    Am J Med; 1989 Apr 17; 86(4A):119-23. PubMed ID: 2523646
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of isradipine in hypertension.
    Shepherd AM, Carr AA, Davidov M, Hamilton J, Schnaper H, Velasquez M, Brockway B, Prisant LM, Hamilton B, Gonasun L.
    J Cardiovasc Pharmacol; 1989 Apr 17; 13(4):580-5. PubMed ID: 2470995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.